【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 17
2 Introduction 18
2.1 Acquired Gene or Chromosome Alterations Overview 18
3 Products under Development 19
3.1 Acquired Gene or Chromosome Alterations – Pipeline Products by Stage of Development 19
3.2 Acquired Gene or Chromosome Alterations – Pipeline Products by Territory 20
3.3 Acquired Gene or Chromosome Alterations – Pipeline Products by Regulatory Path 21
3.4 Acquired Gene or Chromosome Alterations – Pipeline Products by Estimated Approval Date 22
4 Acquired Gene or Chromosome Alterations – Pipeline Products under Development by Companies 23
4.1 Acquired Gene or Chromosome Alterations Companies – Pipeline Products by Stage of Development 23
4.2 Acquired Gene or Chromosome Alterations – Pipeline Products by Stage of Development 26
5 Acquired Gene or Chromosome Alterations Companies and Product Overview 36
5.1 Abbott Diagnostics Company Overview 36
5.1.1 Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 36
5.2 Agendia NV Company Overview 177
5.2.1 Agendia NV Pipeline Products & Ongoing Clinical Trials Overview 177
5.3 AltheaDx, Inc. Company Overview 178
5.3.1 AltheaDx, Inc. Pipeline Products & Ongoing Clinical Trials Overview 178
5.4 Amarantus Bioscience Holdings, Inc. Company Overview 181
5.4.1 Amarantus Bioscience Holdings, Inc. Pipeline Products & Ongoing Clinical Trials Overview 181
5.5 AstraZeneca Plc Company Overview 183
5.5.1 AstraZeneca Plc Pipeline Products & Ongoing Clinical Trials Overview 183
5.6 AutoGenomics, Inc. Company Overview 185
5.6.1 AutoGenomics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 185
5.7 Biocept, Inc. Company Overview 186
5.7.1 Biocept, Inc. Pipeline Products & Ongoing Clinical Trials Overview 186
5.8 Cepheid Company Overview 189
5.8.1 Cepheid Pipeline Products & Ongoing Clinical Trials Overview 189
5.9 Chinese University of Hong Kong Company Overview 192
5.9.1 Chinese University of Hong Kong Pipeline Products & Ongoing Clinical Trials Overview 192
5.10 Columbia University Company Overview 194
5.10.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview 194
5.11 Dana-Farber Cancer Institute, Inc. Company Overview 195
5.11.1 Dana-Farber Cancer Institute, Inc. Pipeline Products & Ongoing Clinical Trials Overview 195
5.12 DiaCarta Company Overview 196
5.12.1 DiaCarta Pipeline Products & Ongoing Clinical Trials Overview 196
5.13 Exosome Diagnostics, Inc. Company Overview 197
5.13.1 Exosome Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 197
5.14 Gencurix Co., Ltd. Company Overview 198
5.14.1 Gencurix Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 198
5.15 GeneFirst Ltd Company Overview 199
5.15.1 GeneFirst Ltd Pipeline Products & Ongoing Clinical Trials Overview 199
5.16 GenMark Diagnostics, Inc. Company Overview 203
5.16.1 GenMark Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 203
5.17 Genomic Health, Inc. Company Overview 205
5.17.1 Genomic Health, Inc. Pipeline Products & Ongoing Clinical Trials Overview 205
5.18 Genomic Vision Company Overview 207
5.18.1 Genomic Vision Pipeline Products & Ongoing Clinical Trials Overview 207
5.19 GenomicTree, Inc. Company Overview 210
5.19.1 GenomicTree, Inc. Pipeline Products & Ongoing Clinical Trials Overview 210
5.20 German Cancer Research Center Company Overview 212
5.20.1 German Cancer Research Center Pipeline Products & Ongoing Clinical Trials Overview 212
5.21 H. Lee Moffitt Cancer Center & Research Institute, Inc. Company Overview 214
5.21.1 H. Lee Moffitt Cancer Center & Research Institute, Inc. Pipeline Products & Ongoing Clinical Trials Overview 214
5.22 Harvard University Company Overview 216
5.22.1 Harvard University Pipeline Products & Ongoing Clinical Trials Overview 216
5.23 Helmholtz Centre for Infection Research Company Overview 217
5.23.1 Helmholtz Centre for Infection Research Pipeline Products & Ongoing Clinical Trials Overview 217
5.24 HistoRx, Inc. (Inactive) Company Overview 218
5.24.1 HistoRx, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 218
5.25 Illumina, Inc. Company Overview 220
5.25.1 Illumina, Inc. Pipeline Products & Ongoing Clinical Trials Overview 220
5.26 Insight Genetics, Inc. Company Overview 223
5.26.1 Insight Genetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 223
5.27 InVivoScribe Technologies, Inc. Company Overview 225
5.27.1 InVivoScribe Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 225
5.28 Med BioGene Inc. Company Overview 226
5.28.1 Med BioGene Inc. Pipeline Products & Ongoing Clinical Trials Overview 226
5.29 Merrimack Pharmaceuticals, Inc. Company Overview 227
5.29.1 Merrimack Pharmaceuticals, Inc. Pipeline Products & Ongoing Clinical Trials Overview 227
5.30 MolecularMD, Corp. Company Overview 229
5.30.1 MolecularMD, Corp. Pipeline Products & Ongoing Clinical Trials Overview 229
5.31 Multiplicom N.V. Company Overview 230
5.31.1 Multiplicom N.V. Pipeline Products & Ongoing Clinical Trials Overview 230
5.32 Myriad Genetics, Inc. Company Overview 231
5.32.1 Myriad Genetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 231
5.33 Nanosphere, Inc. Company Overview 234
5.33.1 Nanosphere, Inc. Pipeline Products & Ongoing Clinical Trials Overview 234
5.34 New York University Company Overview 237
5.34.1 New York University Pipeline Products & Ongoing Clinical Trials Overview 237
5.35 NIH Office of Technology Transfer Company Overview 238
5.35.1 NIH Office of Technology Transfer Pipeline Products & Ongoing Clinical Trials Overview 238
5.36 Oryzon Genomics S.A. Company Overview 240
5.36.1 Oryzon Genomics S.A. Pipeline Products & Ongoing Clinical Trials Overview 240
5.37 Oxford Biodynamics Limited Company Overview 241
5.37.1 Oxford Biodynamics Limited Pipeline Products & Ongoing Clinical Trials Overview 241
5.38 Panagene Inc. Company Overview 246
5.38.1 Panagene Inc. Pipeline Products & Ongoing Clinical Trials Overview 246
5.39 Pangaea Biotech, S.L. Company Overview 250
5.39.1 Pangaea Biotech, S.L. Pipeline Products & Ongoing Clinical Trials Overview 250
5.40 PDI, lnc. Company Overview 254
5.40.1 PDI, lnc. Pipeline Products & Ongoing Clinical Trials Overview 254
5.41 PharmaSeq, Inc. Company Overview 256
5.41.1 PharmaSeq, Inc. Pipeline Products & Ongoing Clinical Trials Overview 256
5.42 Qiagen N.V. Company Overview 258
5.42.1 Qiagen N.V. Pipeline Products & Ongoing Clinical Trials Overview 258
5.43 RedPath Integrated Pathology, Inc. Company Overview 268
5.43.1 RedPath Integrated Pathology, Inc. Pipeline Products & Ongoing Clinical Trials Overview 268
5.44 Response Genetics, Inc. Company Overview 269
5.44.1 Response Genetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 269
5.45 Rheonix, Inc. Company Overview 272
5.45.1 Rheonix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 272
5.46 Seegene, Inc. Company Overview 274
5.46.1 Seegene, Inc. Pipeline Products & Ongoing Clinical Trials Overview 274
5.47 Shuwen Biotech Co. Ltd. Company Overview 276
5.47.1 Shuwen Biotech Co. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 276
5.48 Syamala Srinivasa Life Sciences Pvt. Ltd Company Overview 284
5.48.1 Syamala Srinivasa Life Sciences Pvt. Ltd Pipeline Products & Ongoing Clinical Trials Overview 284
5.49 Sygnis AG Company Overview 288
5.49.1 Sygnis AG Pipeline Products & Ongoing Clinical Trials Overview 288
5.50 Sysmex Corporation Company Overview 290
5.50.1 Sysmex Corporation Pipeline Products & Ongoing Clinical Trials Overview 290
5.51 The Johns Hopkins University Company Overview 292
5.51.1 The Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 292
5.52 thromboDx Company Overview 294
5.52.1 thromboDx Pipeline Products & Ongoing Clinical Trials Overview 294
5.53 Transbiomed, SL Company Overview 296
5.53.1 Transbiomed, SL Pipeline Products & Ongoing Clinical Trials Overview 296
5.54 Transgenomic, Inc. Company Overview 297
5.54.1 Transgenomic, Inc. Pipeline Products & Ongoing Clinical Trials Overview 297
5.55 TrovaGene, Inc. Company Overview 299
5.55.1 TrovaGene, Inc. Pipeline Products & Ongoing Clinical Trials Overview 299
5.56 University of California, Irvine Company Overview 301
5.56.1 University of California, Irvine Pipeline Products & Ongoing Clinical Trials Overview 301
5.57 Vela Diagnostics Company Overview 302
5.57.1 Vela Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 302
5.58 Xiamen Zeesan Biotech Co.,Ltd Company Overview 307
5.58.1 Xiamen Zeesan Biotech Co.,Ltd Pipeline Products & Ongoing Clinical Trials Overview 307
6 Acquired Gene or Chromosome Alterations- Recent Developments 311
7 Appendix 345
7.1 Methodology 345
7.2 About GlobalData 347
7.3 Contact Us 348
7.4 Disclaimer 348
【レポート販売概要】
■ タイトル：世界における後天的遺伝子変異または後天的染色体変異検査製品のパイプライン動向2015■ 英文：Acquired Gene or Chromosome Alterations - Pipeline Review, 2015
■ 発行日：2015年10月1日
■ 調査会社：GlobalData
■ 商品コード：GDME0077EPD
■ 調査対象地域：グローバル
- Miller Energy, Inc.：石油・ガスの開発・生産動向及びコスト分析– 2012Miller Energy, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis – 2012 Summary Miller Energy, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key …
- ツーリングの世界市場：ダイ＆金型、鍛造、ジグ＆治具、工作機械、ゲージThe global tooling market size is expected to reach $368.5 billion in 2026, from $200.8 billion in 2018, growing at a CAGR of 8.0% from 2019 to 2026. Tooling or tools are a fundamental part of every manufacturing industry. The tooling process includes molding, punching, forging, machining, boring, drilling, and gauging. The instruments required for this purpose include dies & molds and machine too …
- 世界の主要画像診断装置（医療機器）メーカー分析2014Complete report $14,500. Individual company assessments $2,450. The report is available by company, section, market segment, and can be custom-tailored to your specific information needs and budget. This unique study is designed to provide diagnostic imaging industry executives with strategically significant competitor information, analysis and insight crucial to the development and im …
- 変圧器の世界市場2015-2019About Electric Transformer Electric transformers are special devices used to step-up and step-down voltage in transmission and distribution applications. Transformers can be divided into two types: power transformers and distribution transformers. Power transformers are used in the high voltage transmission network as voltage step up devices. They operate at full load. Distribution transformers ar …
- 小麦タンパク質の世界市場分析：製品別（小麦グルテン、小麦タンパク質単離物、テクスチャード、加水分解物）、濃度別（75%、80%、95%）、用途別（乳製品、製パン、サプリメント、動物飼料）、セグメント予測、2014-2025The global wheat protein market is expected to reach USD 2.15 billion by 2025, according to a new report by Grand View Research, Inc. Globally increasing consumer preference for meat free diets and rising applications in end user industries has been major factors driving the market growth. In addition, growing incidences of lactose intolerance has led to the increased demand for the market. Wheat …
- プロダクトスチュワードシップの世界市場予測（～2023年）Increased adoption of product stewardship solutions and services by enterprises for building their brand image is expected to drive the overall growth of the product stewardship market across the globe.The product stewardship market is projected to grow from USD 777 million in 2018 to USD 1,143 million by 2023, at a Compound Annual Growth Rate (CAGR) of 8.0% from 2018 to 2023. Growing awareness am …
- 世界のビックデータ市場：Global Big Data Market 2014-2018TechNavio's analysts forecast the Global Big Data market to grow at a CAGR of 34.17 percent over the period 2013-2018. One of the key factors contributing to this market growth is the need to upgrade business processes and improve productivity. The Global Big Data market has also been witnessing the increase in market consolidation. However, the lack of awareness about the potential of big data co …
- 世界のスクラロース市場2015The Global Sucralose Industry Report 2015 is a professional and in-depth study on the current state of the Sucralose industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Sucralose market analyses is provided for the international markets including development trends, competitive landscape analysis, and …
- バイオバーデン試験の世界市場：装置（PCR、顕微鏡、微生物識別システム）、消耗品（キット、試薬）The bioburden testing market is expected to reach $565.6 million by 2019 from $354.4 million in 2014, at a CAGR of 9.8% from 2014 to 2019. This market is segmented on the basis of products, test types, applications, end users, and regions. On the basis of end users, the market is segmented into pharmaceutical and biotechnology companies, medical device manufacturers, contract manufacturing organiz …
- 工業用ゴムの世界市場：タイプ別（天然＆合成）、最終用途産業別（自動車、建設、製造、電気＆電子機器、その他）The global industrial rubber market was valued at $29.8 billion in 2018 and is projected to reach $44.6 billion by 2026, growing at a CAGR of 5.2% from 2019 to 2026. Industrial rubber are polymers, specifically elastomer which can stretch and shrink. Industrial rubber can be produced from natural sources such as from latex found in trees or rubber and can be synthesized on an industrial scale. Glo …
- 世界のVoice over Mobile Broadband (VoMBB)市場動向（2012-2016）Global Voice over Mobile Broadband (VoMBB) Market 2012-2016 Voice over Mobile Broadband, or VoMBB, has been recently gaining traction in the Global Telecom industry and is unanimously expected to generate huge revenue for telecom network operators in the coming years. Conceptually, VoMBB is about encompassing carrier-grade voice calls over LTE, Wi-Fi and HSPA/HSPA+ networks. While Wi-Fi is a nifty …
- 世界のスマートグリッド分析：Analyzing the Global Smart GridSmart Grids are electrical grids which use information and communications technology to gather and act on information, such as information about the behaviors of suppliers and consumers, in an automated fashion to improve the efficiency, reliability, economics, and sustainability of the production and distribution of electricity. For a century, utility companies have had to send workers out to gat …
- 中南米の再生可能エネルギー政策ハンドブック2016North and South America Renewable Energy Policy Handbook 2016 Summary “North and South America Renewable Energy Policy Handbook 2016” is among the latest region specific policy reports from GlobalData, which offers comprehensive information on major policies governing renewable energy markets in the region. The report covers nine key countries in the region, providing the current and future renewa …
- PTH/IO PTHの市場別医療検査数および販売予測This new report from Venture Planning Group provides analysis of PTH/IO PTH testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment. Geographic Coverage France, Germany, Italy, Japan, Spain, UK, USA Market Segmentation Centralized Testing - Hospitals - Commercial/Private Laboratories …
- インメモリOLAPデータベースの世界市場2016-2020About In-Memory Database The in-memory database is one of the subcomponents of IMDM, the other subcomponent being in-memory data grid (IMDG). IMDM and in-memory application platform (IMAP) are the components of in-memory computing (IMC), which form the base of this technology. The primary purpose of in-memory processing technology is to enable real-time analyses and allow organizations to store da …
